Natasha Collins
CEO and Founder
Live Willow Capital

Natasha Collins is a Canadian Chartered Professional Accountant with over 20 years of experience advising corporations and executives. As the CEO and Founder of Live Willow Capital Inc., she specializes in guiding pre-seed and venture-stage companies across diverse emerging markets, with a niche focus on non-combustible Next Generation Products (NGPs), including oral nicotine pouches, vapes, and heat-not-burn devices. Her expertise spans early-stage growth, product development, manufacturing, distribution, regulatory processes, strategic planning, and mergers and acquisitions (M&A). Beyond traditional advisory services, Live Willow Capital Inc. offers an innovation lab that collaborates closely with inventors and problem solvers to transform ideas into patentable prototypes, fostering disruptive innovation.

With a strong track record in corporate finance, Natasha has managed 12public listings and participated in M&A transactions and private placements totaling over $600 million. Notably, she was a founding shareholder and advisor to Poda Holdings Inc., a company specializing in patented heat-not-burn device technology, which was acquired by Altria for $100.5 million in 2022. She is also actively involved in venture capital investments, working closely with startups and emerging companies to scale innovative solutions from concept to market. Passionate about identifying high-potential ventures, she combines strategic expertise with hands-on support to drive growth and long-term success in evolving industries.

Sessions with Natasha Collins

Panel
VA, United States, 22202
13:30 - 14:30
In the "ideal" nicotine and tobacco products market, all adult consumers would understand the relative risk of tobacco products, have access to a portfolio of regulated smoke-free products, and be provided with cessation counseling and support. And youth access and usage would be minimal to non-existent. Achieving this vision requires capital investment across all stages — from venture capital funding disruptive innovations to institutional investments in mature corporations – driving the transition toward a harm reduction market. This panel will bring together investors to discuss all these vantage points, whether investors are currently incentivized to put capital to work in the "ideal" state, and what investors are looking for to make investments into the "ideal" state.

Moderators

Speakers